Home » BioJapan 2026
BioJapan 2026
- Optically active β-hydroxy-α-amino acid derivatives for peptide synthesis and drug discovery
- Natural Product Library: To discover new drug candidates
- A Novel Anti-Helicobacter pylori drug
- Cycloimidamicins, Novel natural lead compounds for translation inhibition in Pseudomonas aeruginosa
- Formycin and its derivatives with diverse biological activities
- Expanding Covalent Drug Discovery Beyond Cysteine: Lysine-Targeted Allosteric Inhibition of SHP2
- Environmental Applications of Microorganisms – Beyond Drug Discovery
- Discovery of Novel Bioactive Natural Products: Structure elucidation drives novel scaffold discovery
- Skeletal Editing of Drugs and Natural Products with Benzo-Fused N,O-Heterocycles
- Chemical modifications for siRNA-based anticancer agents
- Phenotypic screening for discovery of antifungals
- Microbial Library: rich in diversity and novelty
- Cordyceps and related fungi: A Promising Microbial Source for Drug Discovery